Clinical Trials Browser

Phase 1 × Small Cell Lung Carcinoma × toripalimab × Clear all

NCT06732258 2024-12-27

Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Phase 1 Not yet recruiting

Small Cell Lung Carcinoma